Gynaecological and obstetrical bleeding in Caucasian women with congenital factor XI deficiency: Results from a twenty-year, retrospective, observational study

Med Clin (Barc). 2019 Nov 29;153(10):373-379. doi: 10.1016/j.medcli.2019.01.029. Epub 2019 Mar 26.
[Article in English, Spanish]

Abstract

Introduction: Factor XI (FXI) deficiency is a mild bleeding disorder, common among Ashkenazis, that may be underestimated in Caucasians. Management of FXI deficiency in women is a challenge, due to its unpredictable bleeding tendency and the little evidence available on this issue.

Objective: To describe gynaecological/obstetrical bleeding complications and to analyze the effectiveness and safety of the antihaemorrhagic treatment among women with FXI deficiency.

Material and methods: A retrospective, observational study of 214 Caucasian subjects with FXI deficiency collected during 20 years (1994-2014) without clinical selection.

Results: We identified 95 women with FXI deficiency. Any haemorrhagic event was communicated by 26/95 (27.4%), being abnormal uterine bleeding the most frequently found (12/95, 12.6%). Nine postpartum haemorrhages were recorded from 136 deliveries (6.6%) in 57 women. Four postsurgical bleeding complications were registered among 25 gynaecological surgeries (16%) in 20 women. Abnormal uterine bleeding, postpartum and postsurgical haemorrhages were related to both a positive bleeding history and FXI:C values ≤43.5%. Prophylaxis with fresh frozen plasma, used in 12/25 (48%) gynaecological surgeries, did not prevent from postoperative bleeding in three cases, but two developed severe adverse reactions.

Conclusion: Women with FXI deficiency, especially those with a positive history of bleeding or FXI:C ≤43.5%, are at risk of developing gynaecological/obstetrical haemorrhages, most of them mild/moderate. Systematic prophylaxis has questionable effectiveness, but might cause severe side effects.

Keywords: Bleeding symptoms; Clínica hemorrágica; Deficiencia de factor XI; Espectro mutacional; Factor XI deficiency; Gynaecological bleeding; Hemorragia ginecológica; Hemorragia obstétrica; Mutation spectrum; Obstetrical bleeding; Procedimientos quirúrgicos; Surgical procedures.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Factor XI Deficiency / complications*
  • Factor XI Deficiency / drug therapy
  • Factor XI Deficiency / ethnology*
  • Female
  • Hemostatics / therapeutic use
  • Humans
  • Metrorrhagia / diagnosis
  • Metrorrhagia / epidemiology
  • Metrorrhagia / etiology*
  • Metrorrhagia / prevention & control
  • Middle Aged
  • Postoperative Hemorrhage / diagnosis
  • Postoperative Hemorrhage / epidemiology
  • Postoperative Hemorrhage / etiology*
  • Postoperative Hemorrhage / prevention & control
  • Postpartum Hemorrhage / diagnosis
  • Postpartum Hemorrhage / epidemiology
  • Postpartum Hemorrhage / etiology*
  • Postpartum Hemorrhage / prevention & control
  • Retrospective Studies
  • Risk Factors
  • Spain / epidemiology
  • White People*
  • Young Adult

Substances

  • Hemostatics